Bicycle Therapeutics Ltd (BCYC) Ownership

20.54 ↑0.28 (1.38%)
As of December 31, 1969, 7:00pm EST.

Institutional Ownership

Baker Bros Advisors LP is the biggest individual institutional holder of Bicycle Therapeutics Ltd (BCYC), owning a total of 9.4 million shares. Combined, the top 47 institutional holders of BCYC own 107.07% of the company with a total of 57.9 million shares.

In the latest ownership report on June 30th 2024, the top 47 institutional holders increased their combined ownership of BCYC by 13 million shares. 16 institutions bought 13,725,304 total additional shares and increased their ownership by an average of 34.83%. However 3 institutions sold 735,675 total shares and decreased their ownership by an average of 11.9%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Bicycle Therapeutics Ltd increased by a net total of 12,989,629 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP13.614%90.174%9,399,9604,457,1372024-06-30
Deep Track Capital, LP5.055%0.000%3,490,50602024-06-30
Morgan Stanley - Brokerage Accounts3.567%-18.800%2,463,146-570,2842024-06-30
RA Capital Management, LLC3.263%181.625%2,253,0001,453,0002024-06-30
FCPM III SERVICES BV3.075%0.000%2,122,8922,122,8922024-06-30
Armistice Capital, LLC2.856%17.943%1,972,000300,0002024-06-30
Westfield Capital Management Company, LP2.207%46.677%1,523,856484,9392024-06-30
Tybourne Capital Management (HK) Ltd2.187%-2.286%1,509,713-35,3132024-06-30
First Light Asset Management, LLC2.006%16.070%1,384,768191,7172024-06-30
Fairmount Funds Management LLC1.549%0.000%1,069,1991,069,1992024-06-30
Polar Capital Holdings PLC1.455%0.000%1,004,53502024-06-30
Camber Capital Management LLC1.325%103.333%915,000465,0002024-06-30
EcoR1 Capital, LLC1.318%0.000%910,000910,0002024-06-30
BNP Paribas Investment Partners SA1.286%0.564%888,0814,9762024-06-30
T. Rowe Price Associates, Inc.1.157%98.807%798,501396,8552024-06-30
Candriam Luxembourg S.C.A.1.100%-14.628%759,180-130,0782024-06-30
venBio Select Advisor LLC1.014%0.000%700,000700,0002024-06-30
Woodline Partners LP0.850%0.000%586,622586,6222024-06-30
Perceptive Advisors LLC0.828%0.000%572,000572,0002024-06-30
AXA SA0.803%0.028%554,3201572024-06-30
Parkman Healthcare Partners LLC0.776%2.062%535,06310,8102024-06-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP13.614%90.174%9,399,9604,457,1372024-06-30
Deep Track Capital, LP5.055%0.000%3,490,50602024-06-30
Paradigm Biocapital Advisors LP4.710%-12.416%3,246,759-460,2422024-03-31
Morgan Stanley - Brokerage Accounts3.567%-18.800%2,463,146-570,2842024-06-30
Ridgeback Capital Investments L.p.7.538%4.619%2,264,801100,0002022-12-31
RA Capital Management, LLC3.263%181.625%2,253,0001,453,0002024-06-30
FCPM III SERVICES BV3.075%0.000%2,122,8922,122,8922024-06-30
Armistice Capital, LLC2.856%17.943%1,972,000300,0002024-06-30
Jefferies Financial Group Inc2.834%0.000%1,948,00002023-12-31
Westfield Capital Management Company, LP2.207%46.677%1,523,856484,9392024-06-30
Tybourne Capital Management (HK) Ltd2.187%-2.286%1,509,713-35,3132024-06-30
First Light Asset Management, LLC2.006%16.070%1,384,768191,7172024-06-30
Point72 Asset Management, L.P.3.431%171.862%1,299,500821,5002023-09-30
BRAIDWELL LP3.405%0.000%1,289,8721,289,8722023-09-30
RTW INVESTMENTS, LLC4.189%-1.386%1,258,587-17,6892022-12-31
Fairmount Funds Management LLC1.549%0.000%1,069,1991,069,1992024-06-30
Polar Capital Holdings PLC1.455%0.000%1,004,53502024-06-30
Samlyn Capital, LLC3.288%-23.661%987,888-306,1972022-12-31
Camber Capital Management LLC1.325%103.333%915,000465,0002024-06-30
Suvretta Capital Management, LLC1.327%0.000%914,47602024-03-31
HHG PLC2.415%-28.907%910,930-370,3942023-09-30
EcoR1 Capital, LLC1.318%0.000%910,000910,0002024-06-30
SV Life Sciences Advisers, LLC3.021%0.000%907,03202022-09-30
BNP Paribas Investment Partners SA1.286%0.564%888,0814,9762024-06-30
Eventide Asset Management, LLC2.842%0.000%853,80002022-12-31
T. Rowe Price Associates, Inc.1.157%98.807%798,501396,8552024-06-30
Sio Capital Management, LLC2.112%-17.729%796,933-171,7382023-09-30
Candriam Luxembourg S.C.A.1.100%-14.628%759,180-130,0782024-06-30
Verition Fund Managegment, LLC1.945%-19.189%740,539-175,8432023-12-31
venBio Select Advisor LLC1.014%0.000%700,000700,0002024-06-30
Woodline Partners LP0.850%0.000%586,622586,6222024-06-30
BlackRock Inc0.834%14.634%575,03073,4072024-03-31
Perceptive Advisors LLC0.828%0.000%572,000572,0002024-06-30
AXA SA0.803%0.028%554,3201572024-06-30
Parkman Healthcare Partners LLC0.776%2.062%535,06310,8102024-06-30
Logos Global Management LP1.416%-30.667%520,000-230,0002023-06-30
Deerfield Management Co1.190%0.000%448,753448,7532023-09-30
Schonfeld Strategic Advisors LLC0.610%707.677%420,800368,7002024-03-31
Kennedy Capital Management Inc1.094%165.777%416,485259,7802023-12-31
Soleus Capital Management, L.P.1.122%0.000%411,80002023-06-30
Nomura Holdings Inc1.090%0.000%400,000400,0002023-06-30
Bank of America Corp0.576%-13.985%396,812-64,5192024-03-31
Two Sigma Investments LLC1.282%114.668%380,654203,3322022-06-30
Millennium Management LLC1.124%104.265%333,701170,3342022-06-30
FMR Inc0.782%-23.964%287,147-90,5002023-03-31
Two Sigma Advisers, LLC0.885%-36.729%262,700-152,5002022-09-30
PURA VIDA INVESTMENTS, LLC0.718%16.383%213,12130,0002022-09-30

Mutual Fund Ownership

T. Rowe Price Health Sciences is the biggest individual fund holder of Bicycle Therapeutics Ltd (BCYC), owning a total of 1.3 million shares. Combined, the top 51 mutual fund holders of BCYC own 25.12% of the company with a total of 12.8 million shares.

In the latest ownership report on October 31st 2024, the top 51 fund holders increased their combined ownership of BCYC by 1 thousand shares. 1 funds bought 602 total additional shares and increased their ownership by an average of 0.48%. However 1 funds sold 1,632 total shares and decreased their ownership by an average of 0.59%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Bicycle Therapeutics Ltd decreased by a net total of -1,030 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
iShares Biotechnology ETF0.395%-0.595%272,782-1,6322024-10-31
Handelsbanken Hälsovård Tema (A1 SEK)0.290%0.000%200,00002024-10-31
Embark Small Cap Equity Institutional0.184%0.476%127,0306022024-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
T. Rowe Price Health Sciences1.930%2.609%1,332,27733,8712024-09-30
Polar Capital Biotech S Inc1.448%0.000%1,000,00002024-09-30
Eventide Healthcare & Life Sciences I2.842%0.000%853,80002022-12-31
Harbor Small Cap Growth Instl1.227%21.801%847,470151,6902024-09-30
Westfield Capital Mgt Co Sm-Cap Gr Eq1.009%50.817%695,780234,4402024-06-30
Candriam Eqs L Biotech C USD Cap0.809%22.620%558,461103,0192024-09-30
BNP Paribas Health Cr Innovtr Cl Cap0.760%-11.884%524,805-70,7772024-09-30
Candriam Global Equities Oncology0.713%34.115%492,114125,1802024-09-30
Belfius Equities Cure C Cap0.713%0.000%492,11402024-09-30
Janus Global Life Science A USD1.445%2.999%433,81912,6322022-12-31
Janus Henderson Global Life Sciences1.023%-18.864%385,754-89,6882023-09-30
Janus Henderson Global Life Sciences D1.023%-18.864%385,754-89,6882023-09-30
Janus Selection Global Life Science AUSD0.791%-20.449%298,274-76,6732023-09-30
AXA Framlington Health Fund - R Income0.397%0.000%273,98302024-09-30
AXA Framlington Health R Inc0.726%-2.045%273,983-5,7192023-12-31
iShares Biotechnology ETF0.395%-0.595%272,782-1,6322024-10-31
UTM IM GBP AXA Framlington Biotech0.389%0.000%268,72402024-09-30
Fidelity® Select Biotechnology0.706%0.000%266,34702023-11-30
BNP Paribas US Small Cap Classic R0.341%-12.409%235,313-33,3362024-09-30
Principal U.S. Small Cap Equity0.292%0.000%201,900201,9002024-09-30
Principal SmallCap R50.292%19.609%201,90033,1002024-09-30
Handelsbanken Hälsovård Tema (A1 SEK)0.290%0.000%200,00002024-10-31
Janus Henderson Glb Life Scn I2 USD0.515%-4.491%194,237-9,1342023-11-30
Fidelity® Small Cap Growth0.575%0.000%170,82402022-11-30
T. Rowe Price New Horizons0.509%-0.098%150,971-1482022-09-30
Fidelity Advisor Biotechnology I0.218%0.000%150,20002024-09-30
MEDICAL BioHealth EUR Acc0.199%0.000%137,53002024-07-31
Kennedy Micro Cap0.195%-1.355%134,591-1,8492024-09-30
Embark Small Cap Equity Institutional0.184%0.476%127,0306022024-10-31
Fidelity Select Biotechnology0.280%-60.185%106,047-160,3002024-01-31
Loomis Sayles Small Cap Growth CIT D0.327%0.000%96,93596,9352022-03-31
Allianz Biotechnologie P EUR0.137%-0.101%94,629-962024-09-30
BlackRock Health Sciences Term Trust0.132%3.894%91,0063,4112024-08-31
DWS ESG Biotech LC0.233%67.853%88,00235,5742023-10-31
AZ Fd1 AZ Equity - America A-AZ Fd Acc0.209%-0.935%79,116-7472024-01-31
T. Rowe Price Health Sciences Port0.097%335.853%66,70351,3992024-06-30
Allianz Biotechnologie A EUR0.220%0.000%66,04002023-01-31
L&G Future World ESG UK Index L £ Acc0.095%0.000%65,71502024-08-31
Kennedy Small Cap Growth0.093%-5.423%64,071-3,6742024-06-30
Belfius Equities Glob Health Care C$ Cap0.209%24.000%62,00012,0002022-07-31
APO Medical Opportunities R0.088%0.000%60,67502024-05-31
AlphaCentric LifeSci Healthcare I0.087%-33.333%60,000-30,0002024-03-31
Fidelity® Small Cap Growth K60.149%0.000%44,13502022-11-30
Harbor Disruptive Innovation Instl0.149%-11.168%44,112-5,5462022-09-30
Janus Henderson Horizon Bio E2 USD Acc0.133%-4.956%39,797-2,0752023-02-28
L&S Equity Growth0.116%-7.683%34,725-2,8902022-12-31
Janus Henderson Hrzn Biotec E2 USD0.113%2.080%33,9166912023-05-31
Bellevue Biotech DT CHF0.087%0.000%26,00026,0002023-02-28
TD Health Sciences - I0.079%51.328%23,5868,0002022-12-31
Bellevue (Lux) Bellevue Biotech I USD0.077%-36.111%23,000-13,0002022-12-31
Fidelity® NASDAQ Composite Index®0.057%0.000%17,14402023-04-30

Discussions

Please log in or register to share your thoughts.

BumOfWolfStreet

$BCYC who else finds themselves here after liquidating their positions for a loss only to bash on how seriously fcked up the stock market is

0 Like Report
haltdaytrader

$BCYC the greatest stock of all time
will not bow to the shorts
oh yeah

0 Like Report